Abstract
Glucose is the predominant metabolic fuel utilized by the brain (McCall 1993; Sokoloff 1989; Hasselbalch et al. 1994). Under physiological conditions glucose oxidation accounts for virtually all of the oxygen consumed by the brain, and the brain respiratory quotient approaches 1.0. The brain can utilize additional substrates, such as ketone bodies, but only when the circulating levels of these are elevated well above normal postabsorptive levels, as during prolonged fasting (Hasselbalch et al. 1994). Because the brain cannot synthesize glucose or store more than a few minutes’ supply as glycogen, it requires a continuous supply of glucose from the circulation for its survival and, therefore, for survival of the individual. At normal (or elevated) plasma glucose concentrations the rate of blood-to-brain glucose transport exceeds the rate of brain glucose metabolism. However, as the plasma glucose concentration falls below the physiological range blood-to-brain glucose transport becomes rate limiting to brain glucose metabolism. Given the survival value of maintenance of the plasma glucose concentration, it is not surprising that physiological mechanisms that very effectively prevent or correct hypoglycemia evolved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE (1985) Enhanced glycemic responsiveness to epinephrine in insulin dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 75: 1842–1851
Bloomgarden ZT, Liljenquist JE, Cherrington AD, Rabinowitz D (1978) Persistent stimulatory effect of glucagon on glucose production despite downregulation. J Clin Endocrinol Metab 47: 1152–1155
Bolli GB, De Feo P, DeCosmo S, Perriello G, Ventura MM, Massi-Benedetti M, Santeusanio F, Gerich JE, Brunetti P (1984) A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus. Diabetes 33: 732–737
Bolli G, DeFeo P, Perriello G, De Cosmo S, Ventura M, Campbell P, Brunetti P, Gerich JE (1985) Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest 75: 1623–1631
Boyle PJ, Cryer PE (1991) Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, prolonged hypoglycemia in humans. Am J Physiol 260: E395–E402
Boyle PJ, Liggett SB, Shah SD, Cryer PE (1988) Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. J Clin Invest 82: 445–449
Boyle PJ, Shah SD, Cryer PE (1989) Insulin, glucagon and catecholamines in the prevention of hypoglycemia during fasting in humans. Am J Physiol 256: E651–E661
Brodows RG, Ensinck JW, Campbell RG (1976) Mechanism of cyclic AMP response to hypoglycemia in man. Metabolism 25: 659–663
Cherrington AD, Williams PE, Shulman GI, Lacy WW (1981) Differential time course of glucagon’s effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30: 180–187
Cherrington AD, Diamond MP, Green DR, Williams PE (1982) Evidence for an intrahepaic contribution to the waning effect of glucagon on glucose production in the conscious dog. Diabetes 31: 917–922
Connolly CC, Adkins-Marshall BA, Neal DW, Pugh W, Jaspan JB, Cherringon AD (1992) Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog. Diabetes 41: 1308–1319
Cryer PE (1993a) Glucose counterregulation: the physiological mechanisms that prevent or correct hypoglycemia. In: Frier BM, Fisher BM (eds) Hypoglycaemia and diabetes. Arnold, London, pp 34–55
Cryer PE (1993b) Glucose counterregulation: the prevention and correction of hypoglycemia in humans. Am J Physiol 264: E149–55
Cryer PE (1993c) Catecholamines, pheochromocytoma and diabetes. Diabetes Rev 1: 309–317
Cryer PE (1994) Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43: 1378–1389
Cryer PE, Fisher JN, Shamoon H (1994) Hypoglycemia. Diabetes Care 17: 734–755
De Feo P, Perriello G, Torlone E, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB (1989a) Demonstration of a role of growth hormone in glucose counterregulation. Am J Physiol 256: E835–E843
DeFeo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB (1989b) Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 257: E35–E42
Ensinck JW, Walter RM, Palmer JP, Brodows RG, CampbelL RG (1976) Glucagon responses to hypoglycemia in adrenalectomized man. Metabolism 25: 227–232
Fanelli C, DeFeo P, Porcellatti F, Perriello G, Torlone E, Santeusanio F, Brunetti P, Bolli GB (1992) Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation by stimulating lipolysis. J Clin Invest 89: 2005–2013
Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, DiVincenzo A, Annibale B, Lepore M, Lalli C, Del Sindaco P, Brunetti P, Bolli GB (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37: 797–807
Ferraninni E, DeFronzo RA, Sherwin RS (1982) Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Am J Physiol 242: E73 - E81
Frier BM, Corrall RJM, Ratcliffe JG, Ashby JP, McClemont EJW (1991) Autonomic neural control mechanisms of substrate and hormonal responses to acute hypoglycaemia in man. Clin Endocrinol (Oxf) 14: 425–433
Frizzell RT, Campbell PJ, Cherrington AD (1988) Gluconeogenesis and hypoglycemia. Diabetes Metab Rev 4: 51–70
Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM (1976) The role of adrenergic mechanisms in the substrate and hormonal response to insulin induced hypoglycemia in man. J Clin Invest 58: 7–15
Gerich J, Davis J, Lorenzi M, Rizza R, Bohannon N, Karam J, Lewis S, Kaplan R, Schultz T, Cryer P (1979) Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol 236: E380–E385
Hansen I, Firth R, Haymond M, Cryer P, Rizza R (1986) The role of autoregulation of hepatic glucose production in man: response to a physiologic decrement in plasma glucose. Diabetes 35: 186–191
Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB (1994) Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 14: 125–131
Havel PJ, Taborsky GJ Jr (1994) The contribution of the autonomic nervous system to increased glucagon secretion during hypoglycemic stress: update 1994. In: Underwood LE (ed) The endocrine pancreas, insulin action and diabetes. The Endocrine Society, Bethesda, pp 201–204
Heller SR, Cryer PE (1991) Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. Am J Physiol 261: E41–E48
Hilsted J, Frandsen H, Holst JJ, Christensen NJ, Nielsen SL (1991) Plasma glucagon and glucose recovery after hypoglycemia: the effect of total autonomic blockade. Acta Endocrinol (Copenh) 125: 466–469
Hirsch IB, Marker JC, Smith LJ, Spina RJ, Parvin CA, Holloszy JO, Cryer PE (1991) Insulin and glucagon in the prevention of hypoglycemia during exercise in humans. Am J Physiol 260: E695–E704
Long RG, Albuquerque RH, Prata A, Barnes AJ, Adrian TE, Christofides ND, Bloom SR (1980) Responses of pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycemia in Chaga’s disease. Gut 21: 772–777
Marker JC, Hirsch IB, Smith LJ, Parvin CA, Holloszy JO, Cryer PE (1991) Catecholamines in prevention of hypoglycemia during exercise in humans. Am J Physiol 260: E705–E712
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH (1984) Insulin within islet is a physiologic glucagon release inhibitor. J Clin Invest 74: 2296–2299
McCall AL (1993) Effects of glucose deprivation on glucose metabolism in the central nervous system. In: Frier BM, Fisher BM (eds) Hypoglycaemia and diabetes. Arnold, London, pp 56–71
Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 260: E67–E74
Palmer JP, Henry DP, Benson JW, Johnson DG, Ensinck JW (1976) Glucagon re- sponse to hypoglycemia in sympathectomized man. J Clin Invest 57: 522–525
Palmer JP, Werner PL, Hollander P, Ensinck JW (1979) Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. Metabolism 28: 549–552
Rizza RA, Gerich JE (1979) Persistent effect of sustained hyperglucagonemia on glucose production in man. J Clin Endocrinol Metab 48: 352–355
Rizza RA, Cryer PE, Gerich JE (1979) Role of glucagon, catecholamines and growth hormone in human glucose counterregulation. J Clin Invest 64: 62–71
Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effect of epinephrine on glucose production and clearance in man. J Clin Invest 65: 682–689
Rosen SG, Clutter WE, Berk MA, Shah SD, Cryer PE (1984) Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. J Clin Invest 73: 405–411
Samols E, Stagner JI, Ewart RBL, Marks V (1988) The order of islet microvascular cellular perfusion is B → A → D in the perfused rat pancreas. J Clin Invest 82: 350–353
Sasaki K, Matsuhashi A, Murabayashi S, Aoyagi K, Baha T, Matsunaga M, Takebe K (1983) Hormonal response to insulin-induced hypoglycemia in patients with Shy Drager syndrome. Metabolism 32: 977–981
Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79: 777–781
Sjöbom NC, Adamson U, Lins PE (1989) The prevalence of impaired glucose counterregulation during an insulin infusion test in insulin-treated patients prone to severe hypoglycaemia. Diabetologia 32: 818–825
Sokoloff L (1989) Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers RW, Molinoff P (eds) Basic neurochemistry. Raven, New York, pp 565–590
Starke A, Grundy S, McGarry JD, Unger RH (1985) Correction of hyperglycemia by inducing renal malabsorption of glucose restores the glucagon response to glucose in insulin deficient dogs: implications for human diabetes. Proc Natl Acad Sci USA 82: 1544–1546
Towler DA, Havlin CE, Craft S, Cryer PE (1993) Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42: 1791–1798
Tse TF, Clutter WE, Shah SD, Cryer PE (1983) Mechanisms of postprandial glucose counterregulation in man. J Clin Invest 72: 278–286
Unger RH, Orci L (1995) Glucagon secretion, alpha cell metabolism, and glucagon action. In: De Groot LJ (ed) Endocrinology, 3rd edn. Saunders, Philadelphia, pp 1337–1353
White NH, Skor DA, Cryer PE, Bier DM, Levandoski L, Santiago JV (1983) Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485–491
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cryer, P.E. (1996). Glucagon and Glucose Counterregulation. In: Lefèbvre, P.J. (eds) Glucagon III. Handbook of Experimental Pharmacology, vol 123. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61150-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-61150-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64718-5
Online ISBN: 978-3-642-61150-6
eBook Packages: Springer Book Archive